PB Fintech Under Pressure: IRDAI Rules, UPI MDR Debate & What Investors Should Know

PB Fintech remains under pressure following regulatory developments in the insurance distribution space and the ongoing debate around UPI MDR. Deven Choksey, MD, DR Choksey FinServ Private, discusses the potential impact of IRDAI regulations on the company’s asset-light distribution model and its plans to enter insurance product manufacturing. He explains why shifting towards a product-heavy business could require a stronger balance sheet and affect the valuation investors assign to the company. Choksey also discusses UPI MDR and why any changes could have wider implications for India’s digital payments ecosystem and fintech companies. Like, Share, and Subscribe to our channel Business Today.